Kastle Therapeutics, LLC.
Records under this name other than patents Kastle Therapeutics, LLC. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Kastle Therapeutics, LLC.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,735,364 | Antisense Modulation of Apolipoprotein B Expression Lapsed on the fee record Ended May 27, 2022 · High confidence | Lapsed on the fee record | Ended May 27, 2022 | High confidence |
| US 7,511,131 | Antisense Modulation of Apolipoprotein B Expression Lapsed on the fee record Ended Mar 31, 2021 · High confidence | Lapsed on the fee record | Ended Mar 31, 2021 | High confidence |
| US 7,407,943 | Antisense Modulation of Apolipoprotein B Expression Lapsed on the fee record Ended Aug 5, 2020 · High confidence | Lapsed on the fee record | Ended Aug 5, 2020 | High confidence |
| US 7,888,324 | Antisense Modulation of Apolipoprotein B Expression Lapsed on the fee record Ended Feb 15, 2019 · High confidence | Lapsed on the fee record | Ended Feb 15, 2019 | High confidence |
| US 8,916,694 | SNPS of Apolipoprotein B and Modulation of Their Expression Lapsed on the fee record Ended Dec 23, 2018 · High confidence | Lapsed on the fee record | Ended Dec 23, 2018 | High confidence |
| US RE44,760 | Antisense Modulation of Apolipoprotein B-Expression Formerly held Lapsed on the fee record Ended Sep 28, 2018 · Low confidence | Lapsed on the fee record | Ended Sep 28, 2018 | Low confidence |
| US 7,803,930 | Antisense Modulation of Apolipoprotein B-Expression Surrendered on reissue Surrendered on reissue Feb 11, 2014 · Medium confidence | Surrendered on reissue | Surrendered on reissue Feb 11, 2014 | Medium confidence |